首页> 外文OA文献 >Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide

【2h】

Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide

机译：Coformulated Bictegravir，Emtricitabine，替古罗昔洛酰胺初始治疗后与Bictegravir或Dolutegravir和Emtrickabine / Tenofovir Alafena酰胺

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Paul E. Sax; Edwin DeJesus; Gordon Crofoot; Douglas Ward; Paul Benson; Robin Dretler; Anthony Mills; Cynthia Brinson; Xuelian Wei; Sean E. Collins; Andrew Cheng;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide [J] . Sax Paul E., DeJesus Edwin, Crofoot Gordon, AIDS . 2018,第12期

机译：Coformulated Bictegravir，Emtricicabine，替古罗昔洛酰胺与Bictegravir或Dolutegravir和Emtricicabine / Tenofovir Alafenainide
2. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial [J] . Sax Paul E., Pozniak Anton, Montes M. Luisa, The Lancet . 2017,第10107期

机译：Coformulated Bictegravir，Emtricitabine和Tenofovir Alafenamide与eMtrickabine和替汀·韦昔洛酰胺，用于初步治疗HIV-1感染（GS-US-380-1490）：随机，双盲，多期，第3期，非劣级试验
3. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial [J] . Gallant Joel, Lazzarin Adriano, Mills Anthony, The Lancet . 2017,第10107期

机译：Bictegravir，Emtricicabine和Tenofovir Alafenainide对DoluteGravir，Abacavir和Lamivudine进行HIV-1感染的初始治疗（GS-US-380-1489）：双盲，多期，第3期，随机控制的非劣级试验
4. Quantification of Tenofovir and Emtricitabine in human plasma using high throughput LDTD-MS/MS [C] . Jean Lacoursiere, Annie-Claude Bolduc, Alex Birsan, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：使用高吞吐量LDTD-MS / MS定量人类等离子体中的替诺维尔和Emtrickabine
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Coformulated bictegravir emtricitabine tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide [O] . Paul E. Sax, Edwin DeJesus, Gordon Crofoot, -1

机译：最初用bictegravir或dolutegravir和trictricitabine / tenofovir alafenamide初始治疗后的共同配制的bictegravir恩曲他滨替诺福韦阿拉芬酰胺
7. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials [O] . Chloe Orkin, Edwin DeJesus, Paul E Sax, 2020

机译：固定剂量组合Bictegravir，Emtricitabine和替诺福韦alafenamide与含Dolutegravir的初始治疗方案进行HIV-1感染：第144周的两项随机，双盲，多期，阶段3，非劣级试验结果

Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide

著录项

引文网络

相似文献

相关主题

期刊订阅